Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings

Shares (Q2 2026)
1,185,390
Value
$20.2M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of TBPH by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,185,390$20.2M<0.1%+231,348+24.2%AddedHolders
Q1 2026954,042$15.5M<0.1%−305,899−24.3%ReducedHolders
Q4 20251,259,941$23.6M<0.1%+50,629+4.2%AddedHolders
Q3 20251,209,312$17.7M<0.1%+207,546+20.7%AddedHolders
Q2 20251,001,766$11.0M<0.1%+81,464+8.9%AddedHolders
Q1 2025920,302$8.22M<0.1%+86,359+10.4%AddedHolders
Q4 2024833,943$7.85M<0.1%+69,178+9.0%AddedHolders
Q3 2024764,765$6.16M<0.1%+6,685+0.9%AddedHolders
Q2 2024758,080$6.43M<0.1%−23,505−3.0%ReducedHolders
Q1 2024781,585$7.01M<0.1%−69,623−8.2%ReducedHolders
Q4 2023851,208$9.57M<0.1%+161,647+23.4%AddedHolders
Q3 2023689,561$5.95M<0.1%−24,553−3.4%ReducedHolders
Q2 2023714,114$7.39M<0.1%−300,879−29.6%ReducedHolders
Q1 20231,014,993$11.0M<0.1%−557,657−35.5%ReducedHolders
Q4 20221,572,650$17.6M<0.1%−14,548−0.9%ReducedHolders
Q3 20221,587,198$16.1M<0.1%+206,801+15.0%AddedHolders
Q2 20221,380,397$12.5M<0.1%+141,355+11.4%AddedHolders
Q1 20221,239,042$11.8M<0.1%+362,579+41.4%AddedHolders
Q4 2021876,463$9.68M<0.1%+456,412+108.7%AddedHolders
Q3 2021420,051$3.11M<0.1%+420,051NewHolders
Q2 20210$00.0%−56,014−100.0%Sold outHolders
Q1 202156,014$1.14M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.